Cost-Effectiveness of Universal Low-Dose Computed Tomographic Lung Cancer Screening in Singapore

• by Ruijie Li, John Abisheganaden

• July 8, 2026

Associations between CT characteristics of lung cancer lesions and histologic subtypes in lung cancer screening

• by Erick Suazo-Zepeda, Geertruida H. de Bock, Noa Antonissen, Colin Jacobs, Firdaus A. A. Mohamed Hoesein, Hester A. Gietema, Grigory Sidorenkov, Rozemarijn Vliegenthart, Marjolein A. Heuvelmans

• October 7, 2026

New Study Identifies Hidden Aggressive and Potentially Targetable Neuroendocrine-Like Subtype of Lung Cancer

A new study from researchers at Fox Chase Cancer Center and collaborators across multiple institutions has identified a hidden subset of lung cancers that behave more like aggressive neuroendocrine tumors than traditional non-small cell lung cancer (NSCLC).

• by

• June 3, 2026

• 4 min

The importance of robust genomic testing for patients

Misako Nagasaka, MD, PhD shared how precision oncology has fundamentally shifted the landscape through the identification of actionable genomic targets for lung cancer treatment.

• June 25, 2026

• 1 min